Gene Replacement and Editing
Significant advances in gene replacement therapy and the ability to edit genes have garnered much interest as a treatment approach
Voices of Friedreich's Ataxia (FA)
We Have the Power to Overcome Anything, Together!
Significant advances in gene replacement therapy and the ability to edit genes have garnered much interest as a treatment approach
Nucleic acids are the building blocks of DNA and RNA. Oligonucleotides are chemically synthesized short DNA or RNA molecules that
Design Therapeutics is advancing a novel approach to activate transcription of the FXN gene and restore the production of frataxin
Resveratrol is a naturally occurring compound found in the skin of red grapes. Resveratrol has been under investigation as a
Etravirine (Brand name: Intelence) – Dr. Roberto Testi and his team at the University of Rome and Fratagene recently reported
Dr. Mark Payne, who first described the possibility of frataxin replacement therapy via TAT-Frataxin, has been developing this exciting prospect
Dr. Gino Cortopassi at the University of California Davis and other groups have observed that Nrf2 (Nuclear factor (erythroid-derived 2)-like
Elamipretide is a peptide compound developed by Stealth Therapeutics. It targets the inner mitochondrial membrane where it binds reversibly to
PTC-743 / Vatiquinone (previously EPI-743), is a follow-on or “sister” compound to EPI-A0001, which aims to improve mitochondrial and cellular
It is important to understand the burden of F A, including its extent and the most salient elements. The objective